HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD Prophylaxis

NCT03456817 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

68

Enrollment

OTHER

Sponsor class

Stopped Slow patient accrual and appearance of a toxicity

Conditions

Graft-versus-host-disease
Relapse

Interventions

DRUG: Treatment Arm - high dose ATG
DRUG: Control Arm - standard of care

Sponsor

AHS Cancer Control Alberta